HPV vaccines have transformed cervical cancer prevention, but the next generation of vaccines must better reflect regional disease patterns, including the HPV35 genotype prevalent in Africa.   The recent WHO Global Status Report on Cancer paints a sobering picture. Among the many challenges, human papillomavirus, or HPV, is one of the world’s most serious infectious causes of […] Continue reading ->
Africa can no longer afford to manage cancer care as a perpetual crisis. Instead, policy leaders must recognize this crisis for what it truly is: the ultimate ‘stress test’ for national health systems.  The WHO Global Status Report on Cancer, published this week, highlights the persistent inequities in access to timely cancer diagnosis and treatment […] Continue reading ->
African leaders opened the World Health Summit Regional Meeting at the United Nations complex in Nairobi this week with a unified declaration that two decades of dependence on foreign aid for health is over. “The challenge that I see is that many of the leaders in our continent believe that it is somebody else’s responsibility. […] Continue reading ->
In the latest episode of Trailblazers with Garry, Garry Aslanyan visits Accra, Ghana, to speak with Professor John Owusu Gyapong, Secretary General of the African Research Universities Alliance. Gyapong took on the role in 2024, leading efforts to strengthen research collaboration across African universities. His work focusses on building capacity within the continent and supporting […] Continue reading ->
DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading ->
The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading ->